initi coverag
industri demand appear stabl mute idiosyncrat event drive alpha
broadli neutral neg complex given concern
legaci vendor transit licens saa model well less
construct view ultim growth rate continu slow across
univers stimulu hangov persist custom broadli face financi
challeng howev idiosyncrat event rule stock enter think
stock-pick year seri key event impact variou player
group underli demand core applic remain mute
expect debat center around va dod well return omx
focu integr recent acquisit well
strategi netsmart remain clariti gpo renew well
 path ps athn pace transform growth
trajectori base collector across
term trend monitor remain laser focus dynam compani
privat market potenti excit new issu across pop health
telemedicin revenu cycl lastli continu monitor push toward
vendor consolid primarili occur privat market also
touch player public arena recent
top pick within complex allscript
thing watch pace rip replac pop health growth
industri growth forecast forese emr/pm growth remain lsd
revenu cycl manag like hsd ldd popul health
expect remain all-in expect growth broadli m-hsd rang
valuat price target across complex impli market cap weight price-to-earnings
ep somewhat reflect estim tax reform relat upsid
termin growth rate dcf primari valuat metric compar
price-to-earnings rang averag
upsid risk goal vertic integr across healthcar complex lead
view univers possess strateg option long-term tax windfal
reform well desir shift toward vbc requir new round invest fuel
government/priv sector continu margin pressur face provid
result broader adopt saa base tool enabl improv captur
downsid risk potenti budgetari uncertainti hospit physician
practic given polit uncertainti yield downshift core market growth
challeng emerg tech vendor well privat entrant disrupt share
dynam high growth vertic like pop health custom drive vendor
consolid also result price pressur across complex leverag use
negoti
compani initi outperform athn
pleas see analyst certif import disclosur page report evercor isi affili seek busi
compani cover research report investor awar firm may conflict interest could affect
object report investor consid report singl factor make invest decis
initi coverag
last page report import disclosur regard stock report
tabl content
iv bull bear debat thesi
underli industri demand appear stabl mute seri idiosyncrat event drive volatil
broadli neutral neg complex given concern
legaci vendor transit licens saa model well less construct view
ultim growth rate continu slow across univers stimulu hangov persist
custom broadli face financi challeng howev idiosyncrat event rule stock
enter think stock-pick year seri key event
impact variou player group underli demand core applic remain mute
expect debat center around va dod well return omx
focu integr ei pf well strategi netsmart
remain clariti gpo renew well path ps athn
pace transform growth trajectori base collector across
term trend monitor remain laser focus dynam compani privat
market potenti excit new issu across pop health telemedicin revenu cycl
lastli continu monitor push toward vendor consolid primarili
occur privat market also touch player public arena recent
top pick within complex allscript
thing watch pace rip replac pop health growth consolid
rel valuat point balanc risk reward across complex
ehr growth expect remain mute medium-term
ehr matur market w/ littl greenfield
rip replac result lsd market growth
healthcar provid end-us spend mm
purchas intent continu track lower
market share consolid lead vendor
ye replac current solut
evercor isi offic nation coordin hit sk
growth acceler given shift vbc next-gen tool
tradit featur high level adopt
next-gen compon fuel major segment growth
vbc goal remain dynam similar trend cont
expect all-in growth hsd ldd
number himss survey respond
rate replac vs upgrad
popul health remain key growth driver industri overal
popul health
pop health help address cost chronic diseas
pop health evenli split payer provid
pop health market grow per year
hospit outsid
physician outsid
multipl contract growth slow broadli
metric appear reason compar histor averag well compar tradit softwar univers
risk point balanc risk reward profil idiosyncrat driver vs budgetari uncertainti matur
potenti budgetari uncertainti hospit physician practic given polit uncertainti yield downshift core market growth
challeng emerg tech vendor well privat entrant disrupt share dynam high growth vertic like pop health
custom drive vendor consolid also result price pressur across complex leverag use negoti
goal vertic integr across healthcar complex lead view univers possess strateg option long-term
tax windfal reform well desir shift toward vbc requir new round invest fuel government/priv sector
continu margin pressur face provid result broader adopt saa base tool enabl improv captur
bull bear debat thesi
bull bear debat skew neutral post
cycl acceler
big tech rescu
thesi
recent step-up perform captur potenti upsid
recent deal tax reform boost ep
valuat bake om inflect w/ next phase upsid
come growth acceler deploy
domin market leader underli mix shift limit nt
ep momentum valuat inflect
longer term structur question keep us sidelin despit
initi outperform pt
surviv fittest
last page report import disclosur regard stock report
tabl content
debat transform inpati ei deal
debat valu unlock potenti netsmart
debat vbc precis medicin global move needl
point differenti vs st
iv valuat risk integr vs engin
 conclus initi o/p financi momentum build
broad portfolio solut ambulatori inpati
last five year volatil
healthcar player clinic revenu cycl
offer across acut ambulatori well
thesi non-recur revenue stabil aid core
synergi captur recent acquisit lower tax
rate allow elev ep trajectori netsmart
rate valuat pt outperform pt
ebitda vs average
price-to-earnings vs average
risk challeng aris integr recent
acquisit market growth slow
diversifi new growth vertic
spent year
previous cfo
recent appoint svp oper prior
spent year motorola
previous svp gm nuanc
debat transform inpati ei deal
paragon provid substanti share
august announc acquisit
busi mm cash
includ paragon sever smaller softwar
allscript plan sell paragon integr ehr
solut small/commun hospit market
keep sunris larger institut
ei like gener mm revenu msd
oper margin rev ebitda
transact close octob
market share
instal base split mdrx ownership
outcom deal tbd price paid wasnt oner
paragon
judgement
paragon
plan give
paragon still
plan find new vendor
plan give
paragon
reconsid
plan keep
paragon still
plan keep
plan keep
paragon
reconsid
ei offer attract return synergi upsid ultim top-lin growth trajectori tbd
debat valu unlock potenti netsmart
netsmart solid financi contributor
hsd
appear
estim netsmart ebitda like
mix solid organ perform small tuck-in
given netsmart total debt load mm gross
leverag ebitda
leverag like high especi asset
end stand-alone public entiti
therefor see sort strateg action
like order bring level in-lin
think management commun decis next
netsmart worth per share higher multipl busi vs core equiti upsid depend debt load
discount ebitda termin free flow enterpris netsmart rata valu rata share valu per perpetu growth valu enterpris enterpris valu januari
debat vbc precis medicin global move needl
number addl area drive growth
practic fusion could also help tick growth
global number recent success
intern includ australia uk
continu invest success
centuri cure creat new opportun
trial recruit supplement payer solut
payer solut mco pbm becom
small grow revenu stream
also sign partnership evicor
develop deploy preauthor solut
medic procedur point care
januari announc acquisit
practic fusion mm
price like revenu
practic fusion privat hit compani offer free
ehr product independ physician
current ambulatori custom
practic fusion provid broad access
independ ambulatori space provid anoth leg
transact expect close subject
howev despit growth lever skeptic remain hit mdrx lt growth target
ei drag flat
lsd core basi
vbc tool hsd dd
w/ upsid potenti
nich market hsd
conserv st organ growth given skeptic core
model summari point differenti vs street
point differenti
in-lin st
revenu despit
inclus given
cautiou view core
omx limit recent
deal year w/ step-
st given tax
upsid
netsmart requir
million except per share data fy end septemb organ gp growth revenu margin ep share net incom price-to-earnings premium/discount januari
dcf valuat yield price
dcf deriv pt impli valu base netsmart dcf page
assumpt underli dcf valuat methodolog
year ebita margin assumpt netsmart
termin ebitda multipl netsmart
wacc base beta risk free rate cost debt
tax rate vs prior reform
assumpt impli termin growth rate
netsmart valu base impli ownership jv
discount ebitda termin free flow enterpris revolv use financ total valu valu per perpetu growth valu enterpris enterpris valu januari
screen revers candid w/ netsmart option potenti materi valu unlock
risk point favor risk reward profil synergi captur reform upsid vs integr challeng
potenti integr challeng relat onboard ei acquisit given instabl histor custom base
popul health ramp delay given continu polit shift reimburs environ lack support aco
uptick hospit ambulatori result elev rip replac opportun w/ share consolid competit vendor
manag unabl find strateg outcom netsmart limit valu arbitrag opportun separ entiti
push toward host manag servic thwart increas competit non-tradit vendor tech world
continu bia toward industri consolid distract manag core growth strategi result deterior
conclus initi outperform pt upsid
slight core acceler synergi captur recent acq netsmart option reform revers candid
neutral share allscript given skeptic cadenc growth
recoveri belief netsmart structur complex offer notabl valu unlock
gener thing play anticip howev thing later revers
strong core result ei transact materi benefit report tax reform
strength share continu earli given upsid recent tax reform well
optim notabl share upsid intenational singapor recent competitor downgrad
contend make revers candid non-recur revenu
stabil provid modest upward bia core financi engin aid ep
furthermor think synergi potenti ei recent deal substanti given
duplic cost structur earli check also suggest base respons reason posit
thu believ modest upward bia base profit estim enter
support ep like come lesser report tax rate model vs prior
turn netsmart believ manag must better job help demystifi
complex ownership structur aid strateg option present unlock valu
valuat approach look netsmart separ entiti turn account
dispar growth profil respect dcf impli arbitrag opportun
given dynam see risk reward favor thu initi share o/p rate
thing watch initi guid custom feedback ei pf netsmart updat
initi pt
nothin jb thang
last page report import disclosur regard stock report
tabl content
debat collector busi continu slow
debat success inpati pop health
point differenti vs st
iv valuat risk execut vs option
 conclus initi turn realiti
lead saa provid midst evolut
oh wild ride
healthcar player clinic revenu cycl
offer tradit ambulatori market
recent move hospit market
thesi path improv profitability/fcf encourag
revenu visibility/consist must improv notabl
collector prior anoth valuat inflect
rate valuat pt pt
revenu vs average
ebitda vs average
risk execut challeng aris headcount
 budget cut collector revit
vast major revenu deriv ambulatori
led industri visionari cfo role flux
compani co-found health enthusiast
previous evp cfo jda softwar
join athn busi develop
previous merg healthcar
innov cultur invest faster growth
slow growth year expand revenu
year meant chang compani oper
rapid growth brought layer bureaucraci
imped decis client support
 layoff need product began suffer
fall athn announc lay
workforc peopl
initi cut came sale
sale mm/salesperson
path om readili achiev
execut key manag balanc enhanc profit vs revenu momentum
debat collector busi continu slow
claim growth util anem
like find floor
busi evolut
collect mix also highli unfavor
take rate also modestli mix epocr
collector
unclear headwind may fulli abat athn control part equat
debat success inpati pop health
inpati interest notabl strong low end market
on-board momentum build
despit run govern ehr incent athn
done well commun hospit market
small hospit often price epic
financi difficulti make athn collect
cash improv guarante attract
forc allow athn captur us
hospit market mostli bed
found athn inpati solut
frequent select ehr size
burden integr ehr/rcm cite best featur
word mouth help athn continu gain share
hospit live athenaon
retent remain high cash collect target
pop health disappoint live ramp expect
athn inpati perform reason strong
retain hospit custom sinc
enter inpati market year ago
compani earn call manag note
inpati custom cash
collect prior instal
shi athn goal client
cover athn fee exclud
inpati lesser extent pop health remain key growth upsid
model summari point differenti vs street
swing factor inpati ramp omx pace potenti benefit tax reform
point differenti
line slightli st
inpati success
impress omx st
somewhat reflect
convers
improv lead shift
valuat
methodolog
million except per share data fy end septemb organ provid gp growth revenu margin bpsebita growth revenu ep share net incom ev/rev januari
dcf valuat yield price
dcf deriv pt impli termin growth rate impli ebitda multipl
assumpt underli dcf valuat methodolog
year ebita margin assumpt
termin ebitda multipl
wacc base beta risk free rate cost debt
tax rate vs prior reform
assumpt impli termin growth rate
discount ebitda termin free flow enterpris total valu valu per athn perpetu growth valu enterpris enterpris valu januari
valuat converg w/ softwar peer profit focu enhanc
ev/ bias slowdown core momentum becom key focu metric go forward
risk point balanc risk reward profil margin inflect tax reform vs execut risk growth
potenti revenu momentum slippag ambulatori manag address cost structur footprint headcount
implement woe inpati mix w/ financi shortfal newli board hospit limit near term market oppti
popul health ramp delay given continu polit shift reimburs environ lack support aco
improv gener allow aggress favor capit alloc supplement acceler ep growth
uniqu market posit technolog advantag result premium multipl due potenti strateg option lt
step-up underli util favor case mix shift result resurg collect dollar aid ambulatori growth
conclus initi pt upsid
valuat bake om inflect w/ next phase upsid come growth acceler deploy
notabl posit share athn believ ep power materi
underst market fail appreci new revenu driver inpati pop health
thesi correct ambulatori disappoint pop health mix share
ralli materi post file well-known activist given optim strateg altern
manag ultim decid address long-term valu creation via self-help approach
leav share key crossroad ahead expect step om gener
remain bullish prospect profit inflect also believ market share captur
inpati underappreci also contend non-linear transit athn
long histori growth-centr compani refocus margin capit alloc
typic take time also offer period volatil organ adapt shift
like even true athn case base busi still face
uncertainti post stimulu world w/ util mix also help matter collector
valuat standpoint would also note pt impli multipl line
broader softwar peer main sourc potenti upsid vs st like tax reform
thu roll would prefer wait better entri point share would look
opportunist notabl pull-back may present around out-year expect
given dynam see risk reward balanc thu initi share rate
thing watch initi revenue guid q-o-q momentum collector stat
initi pt
last page report import disclosur regard stock report
tabl content
debat what new normal growth us
debat recent book slump temporari structur
debat see return margin expans
financi model wait oper leverag
point differenti vs st
iv valuat risk new vs old growth driver
 conclus initi inflect take time
softwar servic provid facil world-wide
mirror w/ heighten volatil
one largest healthcar player full suit
clinic financi product hospit health
system ambulatori practic
work well intern sustain hsd top-lin
mix shift limit omx restrain tsr
rate valuat pt pt
ebitda vs average
price-to-earnings vs average
risk myriad challeng face hospit high
adopt rate limit rip-and-replac market
portfolio shift base high-valu servic
new ceo brent shafer lead experienc team
previous ceo phillip north america
focus client relationship
prior kpmg
marc naughton cfo evp year
held varieti financ role year
also kpmg
mike nill evp year
respons core global oper
debat what new normal growth us
emr primarili rip replac market
mix shift lower burn book growth correct
forese core growth flattish lsd go forward
onu growth driver hit long-term target
long-term growth target revenu
growth
support view ehr market growth
w/ higher contribut emerg offer
clariti va need view support high-end
manag forecast like come next month
forecast limit growth dod va potenti drive upsid lsd
debat recent book slump temporari structur
model suggest averag deal size upward trend given bia lt servic larger institut
heighten book volatil surpris w/ recent weak clear result work slippag hangov
strong itwork manag
slip
contend shortfal explain expect rebound greater annual visibl
debat see return margin expans
oper margin pressur sinc
servic revenu grown total revenue sinc
mix
contribut margin servic sale much lower
mix shift also evid spike client servic expens
larg driven
sale client servic revenu
sale client servic expens growth
servic centric revenu ramp larg project like limit omx
debat see return margin expans
chang help moderate/revers om declin
 revenu
allow final converg toward
capital-expenditure sale
cap softwar sale
improv convers crucial next evolut stori
model summari point differenti vs street
swing factor dod va cadenc acceler time oper leverag improv
point differenti
forecast st
given conserv
view core va
model omx
mix
primarili tax
premium line
w/ recent trend
million except per share data fy end septemb organ gp growth revenu margin ep share net incom price-to-earnings premium/discount januari
dcf valuat yield price
dcf deriv pt impli termin growth rate impli ebitda multipl
assumpt underli dcf valuat methodolog
year ebita margin assumpt
termin ebitda multipl
wacc base beta risk free rate cost debt
tax rate vs prior reform
assumpt impli termin growth rate
discount ebitda pv termin pv free flow enterpris less total valu valu per perpetu growth valu enterpris enterpris valu januari
valuat modestli elev scarciti valu like explan
share continu converg toward matur softwar peer growth normal inflect
risk point balanc risk reward profil va formal tax reform vs stagnat core momentum
potenti challeng core segment given poor facil fundament high level exist market penetr
va contract could challeng time implement may slow push revenue recognit pressur growth
mix shift away licens softwar subdu mainten growth could allow sustain om pressur limit ep
chang administr hh could result renew focu hit adopt improv incent program govern
continu challeng market peer may result expedit convers replac candid aid base growth
untap balanc sheet could allow elev ep growth return improv support shift aggress polici
conclus initi pt upsid
domin market leader underli mix shift limit nt ep momentum valuat inflect
neutral share despit depress valuat lack convict
core book momentum continu underli mix shift limit ep inflect
share ultim ralli potenti contribut sizeabl va contract well
modest benefit tax reform also brief specul ceo transit
enter much underli dynam remain constant model strong hsd top-
line growth profit growth ex tax reform constrain continu shift saa servic
examin matur softwar compani undergon transit would note
took sever year adjust less licens softwar carri heavi margin
also acknowledg quarterli book volatil like remain elev work
contract challeng predict time perspect larger deal norm
furthermor cite modest uncertainti regard sizeabl va contract although
belief govern ultim fund much need project earli
order becom construct either need enhanc confid lsd core due
stabl improv rip replac environ materi step-up convers
hope would sizeabl gener could translat improv capit
return allow multipl sustain elev rate ep growth improv dd
see potenti occur turn monitor underli trend close
thing watch updat va time omx trajectori pace work book
initi pt
last page report import disclosur regard stock report
